Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Paolo
Nov 29, 2023, 16:26 |
Blog
Top 10 abstracts to keep an eye on for SABCS 23 by Paolo Tarantino
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X/Twitter: "10 days to…
Nov 27, 2023, 17:43 |
Blog
Paolo Tarantino: Can we get rid of the anthracyclines from the KN522 regimen?
Paolo Tarantino, Researcher at the European Institute of Oncology and clinical research fellow at the…
Nov 19, 2023, 17:20 |
Drugs
Paolo Tarantino: More important than ever to perform NGS/ctDNA to select the best 2L treatment after CDK4/6i
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X/Twitter: “Capivasertib is now…
Nov 14, 2023, 18:56 |
Blog
Sandra Misale: Today, we celebrate Paolo's achievements
Sandra Misale, Assistant professor at Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of…
Nov 11, 2023, 17:08 |
Blog
Katsuaki Maehara: Great article about ADCs by Paolo Tarantino
Katsuaki Maehara, Director of Medical Education Colleagues, recently shared the following on X/Twitter: "Great article…
Nov 6, 2023, 04:03 |
Blog
Paolo Tarantino: Make sure not to miss our presentation of RELIEVE at the San Antonio Breast Cancer Symposium (SABCS23)
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X/Twitter: "Trastuzumab Deruxtecan (T-DXd)…
Nov 2, 2023, 09:32 |
Dialogues
5min OncoDaily Updates with Chandler Park: Paolo Tarantino on the future of triple negative breast cancer with the IMPRESSIVE phase Ib/II BEGONIA study
[embed]https://www.youtube.com/watch?v=vSQg9swI61A&t=7s[/embed]
Oct 31, 2023, 15:37 |
Blog
Paolo A. Ascierto: I owe it every day to Giuseppe, to Carla, to Rosina, to Gabriele, to the many who are still part of that 50% who are less lucky
Quoting Paolo A. Ascierto, Director Department of Melanoma, Cancer Immunotherapy, Development Therapeutics at the National…
Oct 31, 2023, 09:39 |
Insight
Paolo A. Ascierto: The history of melanoma is changing!
Paolo A. Ascierto, Director Department of Melanoma/Skin Cancers, Cancer Immunotherapy and Development Therapeutics at IRCCS,…
Oct 20, 2023, 20:02 |
Insight
10 ESMO23 breast cancer abstracts not to miss by Paolo Tarantino
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on Twitter: "ESMO23 will have…
12
13
14
15
16
All:
264
Posts:
131 - 140
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube